India, the 'pharmacy of the world' banks on bilateral talks for relief from planned US tariffs

Indian drugmakers are seeking bilateral discussions with the U.S. to avoid President Donald Trump’s proposed 25% tariff on pharmaceutical imports, according to the Indian Pharmaceutical Alliance (IPA). The U.S. is India's largest market, accounting for $8.7 billion (31%) of total pharma exports in fiscal 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9FwTLAX
via IFTTT